Patient Empowerment Interventions for Lung Cancer Screening
(Empower-LCS Trial)

Recruiting in Palo Alto (17 mi)

+6 other locations

Overseen byGelareh Sadigh, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of California, Irvine

No Placebo Group

Trial Summary

What is the purpose of this trial?Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Eligibility Criteria

This trial is for English, Spanish, or Vietnamese speakers aged 50-80 who are current smokers or quit within the last 15 years. They must have a history of heavy smoking (20 pack-years), an upcoming primary care appointment at UCI Health in Orange County, and no prior lung cancer or recent chest CT scans.

Inclusion Criteria

I am between 50 and 80 years old.

I have an appointment with my primary care doctor in the next 1-3 months.

I can speak English, Spanish, or Vietnamese.

+3 more

Exclusion Criteria

History of Alzheimer's disease or dementia

I have had a chest CT scan in the last year.

I have had lung cancer before.

Participant Groups

The study tests if reminders to doctors and patients about lung cancer screening eligibility, patient education on lung cancer screening, financial navigation help, and reminders to discuss screening can increase low dose CT scan orders within six months after enrolling.

1Treatment groups

Experimental Treatment

Group I: Empower LCSExperimental Treatment4 Interventions

Patient will be given education material(addressing knowledge barriers); patients' referral to financial navigation resources (addressing health-related social risks); and patients' reminder to discuss LCS during PCP visit. Providers will also be notified of eligibility of their patients to receive LCS.